Earnings History Data for Blueprint Medicines Corporation (BPMC) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Blueprint Medicines Corporation

Blueprint Medicines Corp is an oncology company which is engaged in developing kinase inhibitors for genomically defined cancer subsets. Blueprint Medicines Corp is based in Cambridge, MA.

Release Date	Time	Est. Time	Symbol	Name	Market Cap (M)	Rep. EPS	Est. EPS	Last years EPS	SeekingAlpha Headline	Price	Change	Ext. Hours Price	Ext. Hours Change	52 Week Range	Volume	Avg. Volume	Ext. Hours Volume
01-05-2025	PM		BPMC	Blueprint Medicines Corporation	5,650	N/A	-0.42	-1.32	Blueprint Medicines GAAP EPS of $0.01 beats by $0.47, revenue of $149.4M misses by $7.49M [5/1/2025 7:27 AM]	99.28	9.78 (10.93%)	89.50	0.0 (0.00%)	73.04 - 121.90	1,503,253	0	35,692,231
Google finance search Google investor relations search SeekingAlpha Zacks Finviz CNBC Yahoo Finance MarketWatch Nasdaq quote StockTwits TradingView AlphaQuery InvestorPlace ChartMill Blueprint Medicines Q1 2025 Earnings Preview [4/30/2025 3:09 PM] Blueprint Medicines GAAP EPS of $0.01 beats by $0.47, revenue of $149.4M misses by $7.49M [5/1/2025 7:27 AM] Blueprint Medicines raises 2025 revenue guidance to $720M driven by AYVAKIT growth [5/1/2025 2:02 PM]
13-02-2025	PM		BPMC	Blueprint Medicines Corporation	6,450	-0.79	-0.70	-1.82	Blueprint Medicines reports mixed Q4 results; initiates FY25 outlook [2/13/2025 7:17 AM]	94.99	-8.57 (-8.28%)	98.99	-4.57 (-4.41%)	72.24 - 121.90	2,415,374	1,090,000	5,244
Blueprint Medicines Q4 2024 Earnings Preview [2/12/2025 2:56 PM] Blueprint Medicines reports mixed Q4 results; initiates FY25 outlook [2/13/2025 7:17 AM] Blueprint Medicines projects $680M-$710M AYVAKIT revenue in 2025 with 45% growth [2/13/2025 11:33 AM] Blueprint Medicines Reports Fourth Quarter and Full Year 2024 Results [2025-02-13 07:00AM]
30-10-2024	PM		BPMC	Blueprint Medicines Corporation	5,240	-0.89	-0.97	-2.20	Blueprint Medicines beats Q3 top and bottom-line estimates [10/30/2024 7:09 AM]	89.17	5.77 (6.92%)	91.00	7.60 (9.11%)	53.73 - 121.90	1,634,757	650,000	80,549
Blueprint Medicines Q3 2024 Earnings Preview [10/29/2024 3:43 PM] Blueprint Medicines beats Q3 top and bottom-line estimates [10/30/2024 7:09 AM] Blueprint Medicines Reports Third Quarter 2024 Results and Raises AYVAKIT/AYVAKYT (avapritinib) Full Year Revenue Guidance [2024-10-30 07:00AM] Blueprint Medicines (BPMC) Reports Q3 Loss, Tops Revenue Estimates [2024-10-30 08:10AM] Blueprint Medicines: Q3 Earnings Snapshot [2024-10-30 07:10AM]
01-08-2024	PM		BPMC	Blueprint Medicines Corporation	6,700	-0.80	-1.28	-2.19	Blueprint Medicines GAAP EPS of -$0.80 beats by $0.49, revenue of $138.16M beats by $34.22M [8/1/2024 7:27 AM]	100.93	-7.37 (-6.81%)	108.00	-0.30 (-0.28%)	43.89 - 121.90	2,555,471	630,000	86,487
Blueprint Medicines Q2 2024 Earnings Preview [7/31/2024 12:08 PM] Blueprint Medicines GAAP EPS of -$0.80 beats by $0.49, revenue of $138.16M beats by $34.22M [8/1/2024 7:27 AM]
02-05-2024	PM		BPMC	Blueprint Medicines Corporation	5,700	-1.32	-1.64	-2.15	Blueprint Medicines GAAP EPS of $1.40 beats by $3.05, revenue of $96.12M beats by $14.68M [5/2/2024 7:09 AM]	106.94	12.08 (12.74%)	103.00	8.14 (8.58%)	43.89 - 110.16	1,776,525	720,000	18,192
Blueprint Medicines GAAP EPS of $1.40 beats by $3.05, revenue of $96.12M beats by $14.68M [5/2/2024 7:09 AM] Blueprint Medicines Q1 2024 Earnings Preview [5/1/2024 2:30 PM]
15-02-2024	PM		BPMC	Blueprint Medicines Corporation	4,450	-1.82	-2.04	-2.65	Blueprint Medicines GAAP EPS of -$1.82 beats by $0.22, revenue of $72M beats by $4.9M [2/15/2024 7:10 AM]	87.69	10.89 (14.18%)	77.00	0.20 (0.26%)	37.82 - 94.00	1,428,965	730,000	26,786
Blueprint Medicines Q4 2023 Earnings Preview [2/14/2024 2:07 PM] Blueprint Medicines GAAP EPS of -$1.82 beats by $0.22, revenue of $72M beats by $4.9M [2/15/2024 7:10 AM]
26-10-2023	PM		BPMC	Blueprint Medicines Corporation	2,800	-2.20	-2.39	-2.23	Blueprint Medicines GAAP EPS of -$2.20 beats by $0.18, revenue of $56.57M beats by $5.92M [10/26/2023 7:11 AM]	55.05	11.09 (25.23%)	46.48	2.52 (5.73%)	37.82 - 68.00	3,318,698	700,000	7,607
Blueprint Medicines Q3 2023 Earnings Preview [10/25/2023 2:16 PM] Blueprint Medicines GAAP EPS of -$2.20 beats by $0.18, revenue of $56.57M beats by $5.92M [10/26/2023 7:11 AM] Blueprint Medicines stock climbs after Q3 beats [10/26/2023 11:23 AM]
02-08-2023	PM		BPMC	Blueprint Medicines Corporation	3,990	-2.19	-2.58	-2.68	Blueprint Medicines GAAP EPS of -$2.19, revenue of $57.6M [8/2/2023 7:16 AM]	54.31	-9.83 (-15.33%)	59.00	-5.14 (-8.01%)	37.82 - 79.40	2,985,006	810,000	30,686
Blueprint Medicines Q2 2023 Earnings Preview [8/1/2023 1:45 PM] Blueprint Medicines GAAP EPS of -$2.19, revenue of $57.6M [8/2/2023 7:16 AM] Blueprint Medicines dips despite Q2 beat [8/2/2023 2:56 PM]
04-05-2023	PM	8:00 AM ET (May 4)	BPMC	Blueprint Medicines Corporation	2,990	-2.15	-2.66	-1.79	Blueprint Medicines GAAP EPS of -$2.15 beats by $0.51, revenue of $63.28M beats by $21.43M [5/4/2023 7:55 AM]	58.45	6.56 (12.65%)	52.05	0.17 (0.33%)	37.82 - 79.40	1,156,268	480,000	3,736
Blueprint Medicines GAAP EPS of -$2.15 beats by $0.51, revenue of $63.28M beats by $21.43M [5/4/2023 7:55 AM]
16-02-2023	PM	8:00 AM ET (Feb 16)	BPMC	Blueprint Medicines Corporation	2,660	-2.65	-2.73	-0.99	Blueprint Medicines GAAP EPS of -$2.65 beats by $0.02, revenue of $38.78M beats by $5.26M [2/16/2023 7:08 AM]	44.76	0.73 (1.66%)	44.03	0.0 (0.00%)	40.78 - 82.52	456,913	530,000	28,282
Blueprint Medicines GAAP EPS of -$2.65 beats by $0.02, revenue of $38.78M beats by $5.26M [2/16/2023 7:08 AM]
01-11-2022	PM	7:00 AM ET (Nov 1)	BPMC	Blueprint Medicines Corporation	3,170	-2.23	-2.51	2.00	Blueprint Medicines GAAP EPS of -$2.23 beats by $0.28, revenue of $65.97M beats by $22.09M [11/1/2022 8:40 AM]	48.48	-3.36 (-6.49%)	53.10	1.26 (2.43%)	43.46 - 117.86	1,268,324	970,000	110
Blueprint Medicines GAAP EPS of -$2.23 beats by $0.28, revenue of $65.97M beats by $22.09M [11/1/2022 8:40 AM] Blueprint Medicines Outlines 2027 Blueprint to Achieve Precision Medicine at Scale and Reports Third Quarter 2022 Financial Results at Investor Day 2022 [Nov-01-22 08:00AM] Drug/Biotech Stocks' Q3 Earnings on Nov 1: PFE, LLY & More [Oct-31-22 04:07PM] Top 10 Stock Picks of Eli Casdins Casdin Capital [Oct-31-22 08:49AM]
02-08-2022	PM	7:00 AM ET (Aug 2)	BPMC	Blueprint Medicines Corporation	3,090	-2.68	-2.23	-1.86		56.17	5.58 (11.02%)	50.00	-0.60 (-1.19%)	43.46 - 117.86	1,090,564	520,000	691
Blueprint Medicines Q2 2022 Earnings Preview [8/1/2022 1:06 PM] Blueprint Medicines reports Q2 earnings miss; reaffirms FY22 guidance [8/2/2022 7:08 AM] Blueprint jumps 13% ahead of key data readout despite earnings miss [8/2/2022 10:52 AM] Top 10 Stock Picks of Eli Casdins Casdin Capital [Aug-02-22 09:11AM] Blueprint Medicines Reports Second Quarter 2022 Results [Aug-02-22 07:00AM] Drug, Biotech Stocks' Q2 Earnings on Aug 2: GILD, INCY & More [Aug-01-22 01:59PM]
03-05-2022	PM	7:00 AM ET (May 3)	BPMC	Blueprint Medicines	3,566	-1.79	-1.79	0.00	Blueprint Medicines GAAP EPS of -$1.79 beats by $0.10, revenue of $62.73M beats by $22.75M [5/3/2022 7:16 AM]	62.80	3.08 (5.16%)	59.72	0.0 (0.00%)	53.26 - 117.86	536,140	460,000	86,827
Blueprint Medicines Q1 2022 Earnings Preview [5/2/2022 12:12 PM] Blueprint Medicines GAAP EPS of -$1.79 beats by $0.10, revenue of $62.73M beats by $22.75M [5/3/2022 7:16 AM] Blueprint Medicines (BPMC) Reports Q1 Loss, Tops Revenue Estimates [May-03-22 08:35AM] Blueprint Medicines Reports First Quarter 2022 Results [May-03-22 07:00AM]
16-02-2022	PM	7:00 AM ET (Feb 16)	BPMC	Blueprint Medicines Corporation	4,790	-0.99	-0.71	-1.53	Blueprint Medicines GAAP EPS of -$5.40 misses by $4.25, revenue of $107M beats by $2.86M [2/16/2022 7:05 AM]	74.91	-8.30 (-9.97%)	83.21	0.0 (0.00%)	66.29 - 117.86	1,520,613	480,000	110,097
Blueprint Medicines Q4 2021 Earnings Preview [2/15/2022 11:42 AM] Blueprint Medicines GAAP EPS of -$5.40 misses by $4.25, revenue of $107M beats by $2.86M [2/16/2022 7:05 AM] Blueprint Medicines sets 2022 revenue guidance below expectations [2/16/2022 10:53 AM] Blueprint Medicines Reports Fourth Quarter and Full Year 2021 Results [Feb-16-22 07:00AM] Blueprint Medicines (BPMC) Reports Q4 Loss, Tops Revenue Estimates [Feb-16-22 08:15AM]
28-10-2021	PM	7:00 AM ET (Oct 28)	BPMC	Blueprint Medicines Corporation	6,070	-2.00	-1.69	11.16	Blueprint Medicines EPS misses by $0.37, misses on revenue [10/28/2021 7:09 AM]	113.31	9.10 (8.73%)	104.21	0.0 (0.00%)	79.08 - 125.61	799,434	310,000	6,714
Blueprint Medicines Q3 2021 Earnings Preview [10/27/2021 1:25 PM] Blueprint Medicines EPS misses by $0.37, misses on revenue [10/28/2021 7:09 AM] Blueprint Medicines Reports Third Quarter 2021 Financial Results [Oct-28-21 07:00AM] Blueprint Medicines (BPMC) Reports Q3 Loss, Misses Revenue Estimates [Oct-28-21 08:55AM] Blueprint Medicines Corp (BPMC) Q3 2021 Earnings Call Transcript [Oct-28-21 07:30PM]
29-07-2021	PM	7:00 AM ET (Jul 29)	BPMC	Blueprint Medicines Corporation	4,770	-1.86	-1.77	-2.28	Blueprint Medicines EPS misses by $0.05, beats on revenue [7/29/2021 7:08 AM]	84.72	1.81 (2.18%)	82.91	0.0 (0.00%)	66.20 - 125.61	457,047	510,000	2,665
Blueprint Medicines Q2 Earnings Preview [7/28/2021 11:00 AM] Blueprint Medicines and MD Anderson Cancer Center ink strategic research collaboration [7/28/2021 8:55 AM] Blueprint Medicines EPS misses by $0.05, beats on revenue [7/29/2021 7:08 AM] MD Anderson and Blueprint Medicines Announce Strategic Collaboration to Accelerate BLU-222 Development [Jul-28-21 08:00AM] Blueprint Medicines Reports Second Quarter 2021 Financial Results [Jul-29-21 07:00AM] Blueprint Medicines (BPMC) Reports Q2 Loss, Lags Revenue Estimates [Jul-29-21 08:45AM]
29-04-2021	PM	7:00 AM ET (Apr 29)	BPMC	Blueprint Medicines Corporation	5,890	-1.72	-1.80	-2.11	Blueprint Medicines EPS beats by $0.11, beats on revenue [4/29/2021 7:06 AM]	98.87	1.61 (1.66%)	98.87	0.0 (0.00%)	56.00 - 125.61	249,251	320,000	3,701
Blueprint Medicines Q1 Earnings Preview [4/28/2021 12:17 PM] Blueprint Medicines EPS beats by $0.11, beats on revenue [4/29/2021 7:06 AM] Blueprint Medicines Corp. to Host Earnings Call [Apr-29-21 06:30AM] Blueprint Medicines Reports First Quarter 2021 Financial Results [Apr-29-21 07:00AM]
17-02-2021	PM	7:00 AM ET (Feb 17)	BPMC	Blueprint Medicines Corporation	5,400	-1.53	-1.57	-1.35	Blueprint Medicines EPS beats by $0.06, beats on revenue [2/17/2021 7:08 AM]	100.30	7.10 (7.62%)	96.00	2.80 (3.00%)	43.29 - 125.61	700,715	373,824	1,355
Blueprint Medicines EPS beats by $0.06, beats on revenue [2/17/2021 7:08 AM] Blueprint surges after announcing pipeline progress [2/17/2021 2:14 PM]
29-10-2020	PM	7:00 AM ET (Oct 29)	BPMC	Blueprint Medicines Corporation	5,810	11.16	6.49	-1.93	Blueprint Medicines EPS beats by $1.80, beats on revenue [10/29/2020 7:07 AM]	106.84	2.21 (2.11%)	104.63	0.0 (0.00%)	43.29 - 108.50	545,474	423,032	25,691

30-07-2020	PM	7:00 AM ET (Jul 30)	BPMC	Blueprint Medicines Corporation	4,020	-2.28	-2.08	-2.04	Blueprint Medicines EPS misses by $0.15, beats on revenue [7/30/2020 7:05 AM]	73.69	-0.06 (-0.08%)	73.75	0.0 (0.00%)	43.29 - 101.76	300,953	515,465	8,827

06-05-2020	PM		BPMC	Blueprint Medicines Corporation	3,150	-2.11	-2.15	-1.98	Blueprint Medicines EPS beats by $0.05, beats on revenue [5/6/2020 7:06 AM]	59.74	1.61 (2.77%)	0.0	0.0 (0.00%)	43.29 - 102.98	572,180	957,955	0